Uniphar reports "strong trading momentum" as it enters second half

29th July 2025 15:14

(Alliance News) - Uniphar PLC on Tuesday saw its shares edge higher as it reported cross-divisional gross profit growth in the first half of the year.

The Dublin-based healthcare services company reported double-digit growth in adjusted earnings per share for the first half 2025, beatings its expectations.

Uniphar attributed this growth to a strong trading performance, with around 8% organic growth in gross profit and reduced finance costs.

Shares in Uniphar edged 2.2% higher to 337.21 pence on Tuesday afternoon in London.

On a divisional basis, Uniphar Pharma achieved double-digit organic gross profit growth, "and remains on track to deliver double-digit organic gross profit growth for the full year."

Uniphar Medtech delivered high-single digit organic gross profit growth, with its expectations of maintaining this level of growth to the full-year unchanged.

Uniphar Supply Chain & Retail achieved low single-digit organic gross profit growth, said the company, with it also on track to deliver this level of growth for the full-year.

The company noted "strong trading momentum" as it enters the second half of 2025, adding that declining interest rates positively impact its finance costs, with them acting as a tailwind to its EPS expectations.

"Uniphar has had a strong first half, achieving significant organic gross profit growth. We expect to continue this progress into the second half and meet our growth objectives for each of our three divisions for the full year. We remain confident of reaching our EUR200 million earnings before interest, tax, depreciation and amortisation target by 2028, with at least 80% of our growth being organic," said Chief Executive Ger Rabbette.

Uniphar expects to report its interim numbers on September 2.

By Christopher Ward, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Get more news and expert articles direct to your inbox